Cryo-Cell International, Inc.
CCEL
$4.70
-$0.1267-2.63%
AMEX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.93M | 7.97M | 8.02M | 8.07M | 8.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.93M | 7.97M | 8.02M | 8.07M | 8.04M |
| Cost of Revenue | 1.86M | 1.98M | 1.64M | 2.13M | 2.02M |
| Gross Profit | 6.07M | 5.98M | 6.39M | 5.94M | 6.02M |
| SG&A Expenses | 4.26M | 4.64M | 6.01M | 4.15M | 4.02M |
| Depreciation & Amortization | 190.10K | 191.90K | 196.00K | 194.60K | 59.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.44M | 6.91M | 8.15M | 6.66M | 6.34M |
| Operating Income | 1.49M | 1.06M | -123.40K | 1.40M | 1.70M |
| Income Before Tax | 575.10K | 533.70K | -842.40K | 1.38M | 1.47M |
| Income Tax Expenses | 219.30K | 250.90K | 1.02M | 328.20K | 816.40K |
| Earnings from Continuing Operations | 355.80K | 282.90K | -1.86M | 1.05M | 655.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 355.80K | 282.90K | -1.86M | 1.05M | 655.80K |
| EBIT | 1.49M | 1.06M | -123.40K | 1.40M | 1.70M |
| EBITDA | 1.74M | 1.30M | 125.60K | 1.65M | 1.81M |
| EPS Basic | 0.04 | 0.04 | -0.23 | 0.13 | 0.08 |
| Normalized Basic EPS | 0.07 | 0.04 | -0.07 | 0.07 | 0.12 |
| EPS Diluted | 0.04 | 0.03 | -0.23 | 0.13 | 0.08 |
| Normalized Diluted EPS | 0.07 | 0.04 | -0.07 | 0.07 | 0.12 |
| Average Basic Shares Outstanding | 8.08M | 8.08M | 8.07M | 8.06M | 8.12M |
| Average Diluted Shares Outstanding | 8.13M | 8.20M | 8.07M | 8.17M | 8.23M |
| Dividend Per Share | 0.15 | 0.25 | 0.25 | -- | -- |
| Payout Ratio | 340.29% | 714.34% | -108.54% | -- | -- |